Found: 15
Select item for more details and to access through your institution.
Downregulation of MYCN through PI3K inhibition in mouse models of pediatric neural cancer.
- Published in:
- Frontiers in Oncology, 2015, p. 1, doi. 10.3389/fonc.2015.00111
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
<sup>124</sup>I-MIBG PET-CT to monitor metastatic disease in children with relapsed neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.243139
- By:
- Publication type:
- Article
Technical Note: Simplified and practical pretherapy tumor dosimetry — A feasibility study for <sup>131</sup>I‐MIBG therapy of neuroblastoma using <sup>124</sup>I‐MIBG PET/CT.
- Published in:
- Medical Physics, 2019, v. 46, n. 5, p. 2477, doi. 10.1002/mp.13446
- By:
- Publication type:
- Article
Paracrine Signaling Through MYCN Enhances Tumor-Vascular Interactions in Neuroblastoma.
- Published in:
- Science Translational Medicine, 2012, v. 4, n. 115, p. 1, doi. 10.1126/scitranslmed.3002977
- By:
- Publication type:
- Article
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Role of Gastrointestinal Hormones in Neuroblastoma.
- Published in:
- World Journal of Surgery, 2005, v. 29, n. 3, p. 281, doi. 10.1007/s00268-004-7815-4
- By:
- Publication type:
- Article
Tumor dosimetry using [124I]m-iodobenzylguanidine microPET/CT for [131I]m-iodobenzylguanidine treatment of neuroblastoma in a murine xenograft model.
- Published in:
- 2012
- By:
- Publication type:
- journal article
THER-17. BRAF-V600E DEGRADATION AS A THERAPEUTIC STRATEGY IN BRAF-V600E MUTANT GLIOMAS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii117, doi. 10.1093/neuonc/noz036.224
- By:
- Publication type:
- Article
IMMU-06. INVESTIGATING IMMUNOSUPPRESSIVE MECHANISMS IN THE TUMOR MICROENVIRONMENT OF HIGH-RISK NEUROBLASTOMA; AN IMMUNOCOMPETENT, MYCN-DRIVEN, NON-GERMLINE GEM MODEL.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii94, doi. 10.1093/neuonc/noz036.127
- By:
- Publication type:
- Article